Literature DB >> 27880884

Anti-atherosclerosis and cardio-protective effects of the Angong Niuhuang Pill on a high fat and vitamin D3 induced rodent model of atherosclerosis.

Wen-Juan Fu1, Ting Lei2, Zhen Yin2, Jian-Hao Pan1, Yu-Shuang Chai2, Xiao-Yun Xu1, Yi-Xi Yan1, Zhi-Hua Wang1, Jian Ke1, Gang Wu2, Ren-He Xu3, Manish Paranjpe4, Lintao Qu5, Hong Nie6.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: The Angong Niuhuang Pill (ANP) is a well known Chinese traditional therapeutic for the treatment for diseases affecting the Central Nervous System (CNS). Components of the ANP formulation, including Bovis Calculus Sativus, Pulvis Bubali Comus Concentratus, Moschus, Margarita, Cinnabaris, Realgar, Coptidis Rhizoma, Scutellariae Radix, Gardeniae Fructus, Curcumae Radix, and Bomeolum Syntheticum, have been used for the treatment of stroke, encephalitis and emergency meningitis across Asia, especially in China for hundreds of years.
OBJECTIVE: The goal of this study was to investigate the anti-atherosclerosis and cardio-protective effects of ANP administration using a rodent model of atherosclerosis induced by a high fat and vitamin D3.
METHODS: Specific Pathogen-Free (SPF) 78 male SD rats were randomly divided into a control group and 5 atherosclerotic model groups. The atherosclerotic groups were divided to receive either Simvastatin (SVTT, 0.005g/kg), Low-dose ANP (0.125g/kg), Medium-dose ANP (0.25g/kg), and High-dose ANP (0.5g/kg). Following adaptive feeding for one week, atherosclerosis was induced and the atherosclerosis model was established. Experimental drugs (either simvastatin or ANP) or normal saline were administered intragastrically once daily for 9 weeks starting from the 8th week. A carotid artery ultrasound was performed at the 17th week to determine whether atherosclerosis had been induced. After the atherosclerosis model was successfully established, platelet aggregation rates, serum biochemical indices, apoptosis-related Bcl-2, Bax proteins levels in the heart were assayed. Pathological and histological analysis was completed using artery tissue from different experimental different groups to assess the effects of ANP.
RESULTS: ANP significantly decreased aortic membrane thickness, the maximum platelet aggregation rates, and the ratio of low density lipoprotein cholesterol (LDL) to high density lipoprotein cholesterol (HDL). In addition, ANP significantly reduced serum contents of total cholesterol, low density lipoprotein, malondialdehyde, troponin I, high-sensitivity C-reactive protein, and lactate dehydrogenase. ANP markedly improved abnormal pathological conditions of the aorta and heart, and helped to prevent myocardial apoptosis.
CONCLUSIONS: We have demonstrated that ANP has robust ant-atherosclerosis and cardio-protective effects on a high-fat and vitamin D3 - induced rodent model of atherosclerosis due to its antiplatelet aggregation, lipid regulatory, antioxidant, anti-inflammatory and anti-apoptotic properties.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Angong Niuhuang Pill (ANP); Atherosclerosis; High fat diet; Vitamin D(3)

Mesh:

Substances:

Year:  2016        PMID: 27880884     DOI: 10.1016/j.jep.2016.11.015

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  12 in total

1.  Effect of Kangshuanyihao Formula on the Inflammatory Reaction and SIRT1/TLR4/NF-κB Signaling Pathway in Endothelial Injury.

Authors:  Jie Han; Hua-Qin Tong; Song-Yi Cheng; Li Yang; Han-Yu Chen; Jian-Dong Chen; Xiao-Hu Chen
Journal:  Evid Based Complement Alternat Med       Date:  2017-04-30       Impact factor: 2.629

2.  Ethanol extract of Schisandrae chinensis fructus ameliorates the extent of experimentally induced atherosclerosis in rats by increasing antioxidant capacity and improving endothelial dysfunction.

Authors:  Xiu Chen; Jiahong Cao; Yong Sun; Yaolan Dai; Jiali Zhu; Xuemei Zhang; Xiaoqin Zhao; Liwen Wang; Tingting Zhao; Yongbiao Li; Youping Liu; Guihua Wei; Tiane Zhang; Zhiyong Yan
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

3.  UPLC/Q-TOFMS-Based Metabolomics Approach to Reveal the Protective Role of Other Herbs in An-Gong-Niu-Huang Wan Against the Hepatorenal Toxicity of Cinnabar and Realgar.

Authors:  Fangbo Xia; Ao Li; Yushuang Chai; Xiao Xiao; Jianbo Wan; Peng Li; Yitao Wang
Journal:  Front Pharmacol       Date:  2018-06-13       Impact factor: 5.810

Review 4.  The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence.

Authors:  Dan Zhang; Bing Zhang; Jin-Tao Lv; Ri-Na Sa; Xiao-Meng Zhang; Zhi-Jian Lin
Journal:  Pharmacol Res       Date:  2020-05-05       Impact factor: 7.658

Review 5.  Research Progress on Classical Traditional Chinese Medicine Jieyu Pills in the Treatment of Depression.

Authors:  Yuan Wang; Miao Peng
Journal:  Neuropsychiatr Dis Treat       Date:  2020-12-08       Impact factor: 2.570

6.  Kirenol Inhibits B[a]P-Induced Oxidative Stress and Apoptosis in Endothelial Cells via Modulation of the Nrf2 Signaling Pathway.

Authors:  Peramaiyan Rajendran; Abdullah M Alzahrani; Emad A Ahmed; Vishnu Priya Veeraraghavan
Journal:  Oxid Med Cell Longev       Date:  2021-04-23       Impact factor: 6.543

7.  microRNA-363-3p reduces endothelial cell inflammatory responses in coronary heart disease via inactivation of the NOX4-dependent p38 MAPK axis.

Authors:  Tao Zhou; Suining Li; Liehong Yang; Daokang Xiang
Journal:  Aging (Albany NY)       Date:  2021-03-19       Impact factor: 5.682

8.  Synergistic neuroprotective effects of Geniposide and ursodeoxycholic acid in hypoxia-reoxygenation injury in SH-SY5Y cells.

Authors:  Fafeng Cheng; Chongyang Ma; Liangming Sun; Xiaoyu Zhang; Changming Zhai; Changxiang Li; Shuang Zhang; Beida Ren; Shuling Liu; Songnan Liu; Xiangjun Yin; Xueqian Wang; Qingguo Wang
Journal:  Exp Ther Med       Date:  2017-10-30       Impact factor: 2.447

9.  Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE-/- Mice Model of Early and Mid-Term Atherosclerosis.

Authors:  Qinghong Fan; Yujuan Liu; Jiaoyu Rao; Zhe Zhang; Wei Xiao; Tao Zhu; Xiaomeng Chai; Kaihe Ye; Na Ning; Zhen Yin; Yushuang Chai; Yimin Xu; Ruirui Lan; A Verkhratsky; Hong Nie
Journal:  Front Pharmacol       Date:  2020-01-31       Impact factor: 5.810

10.  Development of a Predictive Model to Induce Atherogenesis and Hepato-Renal Impairment in Female Rats.

Authors:  Lucas Pires Guarnier; Paulo Vitor Moreira Romão; Rhanany Alan Calloi Palozi; Aniely Oliveira Silva; Bethânia Rosa Lorençone; Aline Aparecida Macedo Marques; Ariany Carvalho Dos Santos; Roosevelt Isaias Carvalho Souza; Karine Delgado Souza; Emerson Luiz Botelho Lourenço; Arquimedes Gasparotto Junior
Journal:  Biomolecules       Date:  2019-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.